In this study, we reveal that tumor-bound MerTK uniquely contributes to the development of a hot TIME in TNBC, with high MerTK expression on tumors enhancing their sensitivity to ICI therapy (Figure 8). The gene discussed is MERTK; the disease is neoplasm.